Legend Biotech Corp

SOMERSET, NJ · Founded 2015 · CIK 0001801198 · Biotech · Public

CAR-T cell therapies for hematologic malignancies and solid tumors

legendbiotech.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$350M
2 Form D · Apr 2023
41 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$150,450,000
Private capital raisedForm D · SEC$200,000,005
Form D · SECPress

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2779FLUIDFORM INC——
2780Tentarix——
2781Instil Bio, Inc.—$371M
2782Legend Biotech Corp—$350M
2783Sensei Biotherapeutics, Inc.—$349M
2784X4 Pharmaceuticals—$313M
2785Nuvation Bio—$275M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Press

1 article · matched on company name

Founders & Team

From Form D filings · 12 related persons
  • Patrick Casey, Ph.D.Director
  • Tomas HeymanDirector
  • Ying Huang, Ph.D.Director · Executive Officer
  • Darren Ji, M.D., Ph.D.Director
  • Lori MacomberExecutive Officer
  • Li Mao, MDDirector
  • Corazon Sanders, Ph.D.Director
  • Ye Wang, M.S.Director
  • Yuan Xu, Ph.D.Director · Executive Officer
  • Philip Yau, CPADirector
  • Fangliang Zhang, Ph.D.Director
  • Li Zhu, Ph.D.Director

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.